MarginsXMarginsX
Home › Markets › Health Care › ALC

Alcon Inc. (ALC)

ALC trades on NYSE in Health Care, Ophthalmic Goods. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$73.64
-0.65% on the day
Market cap
$36.8B
Large cap
Revenue · 2025
$10.4B
+4.9% on 2024
Net income · 2025
$980.0M
9.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1167379/000116737926000014/0001167379-26-000014-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerALC on NYSE
SectorHealth Care
IndustryOphthalmic Goods
CountrySwitzerland
IPO year2019
SEC CIK0001167379
SEC industry codeOphthalmic Goods
Incorporated inSwitzerland

Financials · 2025

LineValue
Revenue$10.4B
Net income$980.0M
Operating income$1.4B
Net margin9.4%
Operating margin13.1%
Revenue growth+4.9%
Cash$1.5B
Total assets$31.6B
P/E (computed)37.5×
P/S (computed)3.5×

Warning signs

Cash runway
Cash-flow positive
$1.5B cash at December 31, 2025
Share count, 1 year
-1.5%
2024-12-31 to 2025-12-31 · -0.5% over 3 years
Going-concern doubt
No
20-F filed February 24, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-02-24
Cash and burn$1.5B cash; operating cash flow $567.8M a quarter.Report 2025-12-31
Shares outstanding487,427,920 (2025-12-31); 494,616,324 a year earlier; 490,086,981 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Fort Worth, Texas, United StatesPCAOB Form AP 2026-03-17
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
$10.4B$980.0M$2.3B$1.5B$4.7B$10.4B20-F 2026-02-24
FY 2024
2024-12-31
$9.9B$1.0B$2.1B$1.7B$4.6B$9.9B20-F 2026-02-24
FY 2023
2023-12-31
$9.5B$974.0M$1.4B$1.1B$4.7B$9.5B20-F 2026-02-24
FY 2022
2022-12-31
$8.7B$335.0M$1.2B$980.0M$4.6B$8.7B20-F 2025-02-25
FY 2021
2021-12-31
$8.3B$376.0M$1.3B$1.6B$4.1B$8.3B20-F 2024-02-27
FY 2020
2020-12-31
$6.8B-$531.0M$823.0M$1.6B$4.1B$6.8B20-F 2023-02-27
FY 2019
2019-12-31
$7.5B-$656.0M$920.0M$822.0M$3.5B$7.5B20-F 2022-02-15
FY 2018
2018-12-31
$7.2B-$227.0M$1.1B$227.0M$47.0M$7.2B20-F 2021-02-23

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
ALCON, INC.
424B52002-03-21
Latest annual report20-F2026-02-24
Latest quarterly / interim6-K2026-11-10
Latest proxyDEFM14A2025-08-05

Source: SEC EDGAR submissions feed, 528 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-1.1%
1 month+17.7%
3 months+0.8%
Year to date-6.0%
1 year-5.7%
From 52-week high-15.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Ophthalmic Goods

TickerCompanyPriceDayMarket cap
COOThe Cooper Companies Inc.$61.88-1.23%$11.8B
BLCOBausch + Lomb Corporation Common Shares$20.88-1.00%$7.5B
WRBYWarby Parker Inc.$26.23-4.41%$3.3B
EYENational Vision Holdings Inc.$18.74+2.43%$1.5B
STAASTAAR Surgical Company$26.01-1.44%$1.3B
RXSTRxSight Inc.$5.30-0.38%$222.2M
LUCYInnovative Eyewear Inc.$0.7820-3.25%$6.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier